| Breeze Hospice Llc 1909 Dublin Blvd Suite A, Belleville, IL, 62221 | |
| (618) 416-6410 |
News Archive
YM BioSciences Inc. today announced that it has enrolled the first patients in its multi-center Phase II trial of CYT387 administered twice-daily (BID) for the treatment of myelofibrosis.
In anticipation of the September 2011 U.N. High-level Meeting on Non-Communicable Diseases (NCDs), low- and middle-income countries "should not only look at the lessons learned in the control of NCDs in developed countries, but also those from other areas of public health, especially AIDS, which can inform the design of an effective and sustainable response to NCDs in developing countries," Rebecca Dirks from FHI 360 and colleagues write in this PLoS Medicine Policy Forum editorial piece.
Substituting cannabis in place of more harmful drugs may be a winning strategy in the fight against substance misuse. Research published in BioMed Central' open access Harm Reduction Journal features a poll of 350 cannabis users, finding that 40% used cannabis to control their alcohol cravings, 66% as a replacement for prescription drugs and 26% for other, more potent, illegal drugs.
Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.
Research published in the peer-reviewed Journal of General Internal Medicine found that Californians who had moved due to unaffordable housing are significantly more likely to report unmet medical needs compared to people with non-cost-related moves.
› Verified 4 days ago
| Name | Breeze Hospice Llc |
|---|---|
| Location | 1909 Dublin Blvd Suite A, Belleville, Illinois |
| Hospice ID | 141659 |
| Category | Freestanding Hospice |
| Ownership Type | Other |
| Profit Type | OTHER |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 900 |
News Archive
YM BioSciences Inc. today announced that it has enrolled the first patients in its multi-center Phase II trial of CYT387 administered twice-daily (BID) for the treatment of myelofibrosis.
In anticipation of the September 2011 U.N. High-level Meeting on Non-Communicable Diseases (NCDs), low- and middle-income countries "should not only look at the lessons learned in the control of NCDs in developed countries, but also those from other areas of public health, especially AIDS, which can inform the design of an effective and sustainable response to NCDs in developing countries," Rebecca Dirks from FHI 360 and colleagues write in this PLoS Medicine Policy Forum editorial piece.
Substituting cannabis in place of more harmful drugs may be a winning strategy in the fight against substance misuse. Research published in BioMed Central' open access Harm Reduction Journal features a poll of 350 cannabis users, finding that 40% used cannabis to control their alcohol cravings, 66% as a replacement for prescription drugs and 26% for other, more potent, illegal drugs.
Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.
Research published in the peer-reviewed Journal of General Internal Medicine found that Californians who had moved due to unaffordable housing are significantly more likely to report unmet medical needs compared to people with non-cost-related moves.
› Verified 4 days ago
| NPI Number | 1669898805 |
| Organization Name | Breeze Hospice, Llc |
| Address | 1909 Dublin Blvd Belleville, Illinois, 62221 |
| Phone Number | (618)416-6410 |
News Archive
YM BioSciences Inc. today announced that it has enrolled the first patients in its multi-center Phase II trial of CYT387 administered twice-daily (BID) for the treatment of myelofibrosis.
In anticipation of the September 2011 U.N. High-level Meeting on Non-Communicable Diseases (NCDs), low- and middle-income countries "should not only look at the lessons learned in the control of NCDs in developed countries, but also those from other areas of public health, especially AIDS, which can inform the design of an effective and sustainable response to NCDs in developing countries," Rebecca Dirks from FHI 360 and colleagues write in this PLoS Medicine Policy Forum editorial piece.
Substituting cannabis in place of more harmful drugs may be a winning strategy in the fight against substance misuse. Research published in BioMed Central' open access Harm Reduction Journal features a poll of 350 cannabis users, finding that 40% used cannabis to control their alcohol cravings, 66% as a replacement for prescription drugs and 26% for other, more potent, illegal drugs.
Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.
Research published in the peer-reviewed Journal of General Internal Medicine found that Californians who had moved due to unaffordable housing are significantly more likely to report unmet medical needs compared to people with non-cost-related moves.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 88.5 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 80.8 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 96.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 92.3 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
YM BioSciences Inc. today announced that it has enrolled the first patients in its multi-center Phase II trial of CYT387 administered twice-daily (BID) for the treatment of myelofibrosis.
In anticipation of the September 2011 U.N. High-level Meeting on Non-Communicable Diseases (NCDs), low- and middle-income countries "should not only look at the lessons learned in the control of NCDs in developed countries, but also those from other areas of public health, especially AIDS, which can inform the design of an effective and sustainable response to NCDs in developing countries," Rebecca Dirks from FHI 360 and colleagues write in this PLoS Medicine Policy Forum editorial piece.
Substituting cannabis in place of more harmful drugs may be a winning strategy in the fight against substance misuse. Research published in BioMed Central' open access Harm Reduction Journal features a poll of 350 cannabis users, finding that 40% used cannabis to control their alcohol cravings, 66% as a replacement for prescription drugs and 26% for other, more potent, illegal drugs.
Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.
Research published in the peer-reviewed Journal of General Internal Medicine found that Californians who had moved due to unaffordable housing are significantly more likely to report unmet medical needs compared to people with non-cost-related moves.
› Verified 4 days ago
| Home Health Aides | 1 |
| Counselors | 0.5 |
| Medical Social Workers | 0.5 |
| Registered Nurses | 1.5 |
| Other Personnel | 2 |
| Total Employees | 5.5 |
|---|
News Archive
YM BioSciences Inc. today announced that it has enrolled the first patients in its multi-center Phase II trial of CYT387 administered twice-daily (BID) for the treatment of myelofibrosis.
In anticipation of the September 2011 U.N. High-level Meeting on Non-Communicable Diseases (NCDs), low- and middle-income countries "should not only look at the lessons learned in the control of NCDs in developed countries, but also those from other areas of public health, especially AIDS, which can inform the design of an effective and sustainable response to NCDs in developing countries," Rebecca Dirks from FHI 360 and colleagues write in this PLoS Medicine Policy Forum editorial piece.
Substituting cannabis in place of more harmful drugs may be a winning strategy in the fight against substance misuse. Research published in BioMed Central' open access Harm Reduction Journal features a poll of 350 cannabis users, finding that 40% used cannabis to control their alcohol cravings, 66% as a replacement for prescription drugs and 26% for other, more potent, illegal drugs.
Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.
Research published in the peer-reviewed Journal of General Internal Medicine found that Californians who had moved due to unaffordable housing are significantly more likely to report unmet medical needs compared to people with non-cost-related moves.
› Verified 4 days ago
| Others | 1 |
| Total Volunteers | 1 |
|---|
News Archive
YM BioSciences Inc. today announced that it has enrolled the first patients in its multi-center Phase II trial of CYT387 administered twice-daily (BID) for the treatment of myelofibrosis.
In anticipation of the September 2011 U.N. High-level Meeting on Non-Communicable Diseases (NCDs), low- and middle-income countries "should not only look at the lessons learned in the control of NCDs in developed countries, but also those from other areas of public health, especially AIDS, which can inform the design of an effective and sustainable response to NCDs in developing countries," Rebecca Dirks from FHI 360 and colleagues write in this PLoS Medicine Policy Forum editorial piece.
Substituting cannabis in place of more harmful drugs may be a winning strategy in the fight against substance misuse. Research published in BioMed Central' open access Harm Reduction Journal features a poll of 350 cannabis users, finding that 40% used cannabis to control their alcohol cravings, 66% as a replacement for prescription drugs and 26% for other, more potent, illegal drugs.
Fluence Analytics, a manufacturer of industrial and laboratory analytics products, today announced it has signed a distribution agreement with Nihon Rufuto, a Japanese company specializing in the import and domestic sales of scientific instruments.
Research published in the peer-reviewed Journal of General Internal Medicine found that Californians who had moved due to unaffordable housing are significantly more likely to report unmet medical needs compared to people with non-cost-related moves.
› Verified 4 days ago
| Hospice Of Southern Ill, Inc Location: 305 S Illinois St, Belleville, Illinois, 62220 Phone: (618) 416-6410 |
| Family Hospice Of Belleville A Location: 5110 West Main Street, Belleville, Illinois, 62226 Phone: (618) 416-6410 |
| Breeze Hospice Llc Location: 1909 Dublin Blvd Suite A, Belleville, Illinois, 62221 Phone: (618) 416-6410 |